Startup India Government of India
Kingerly Pharmaceuticals Private Limited
Kingerly Pharmaceuticals Private Limited - chemicals in Nagpur, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2023
₹9.15 Lakh
▲ 610% YoY
Net profit · FY 2023
₹1.55 Lakh
Net margin 16.9%
EBITDA · FY 2023
₹2.09 Lakh
EBITDA margin 22.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Open charges
₹3 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Kingerly Pharmaceuticals Private Limited
Data last updated:
Kingerly Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 17 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2021PTC360553.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹10,000. It is led by directors Shikha Nilesh Borkar and Nilesh Tulshidas Borkar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No. 4A 2nd Floor Marartoli Kamptee, Nagpur, Maharashtra, India – 441001.
As per the financials filed for FY 2023, the company reported a revenue of ₹9.15 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.55 Lakh (net margin 16.9%) and EBITDA of ₹2.09 Lakh (EBITDA margin 22.8%).
As per MCA filings, the company has open charges of ₹3 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Kingerly Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0034236).
Company details
CIN U24230MH2021PTC360553
Registration Number 360553
Incorporation Date 17 May 2021
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0034236
Recognitions & Rankings of Kingerly Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0034236
Contact details
Kingerly Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressPlot No. 4A 2nd Floor Marartoli Kamptee, Nagpur, Maharashtra, India – 441001
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Kingerly Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kingerly Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kingerly Pharmaceuticals Private Limited, buy the company report.
Financials of Kingerly Pharmaceuticals Private Limited
FY 2023 filings availableKingerly Pharmaceuticals Private Limited reported revenue of ₹9.15 Lakh (up 610% YoY) for FY 2023.
Revenue · FY 2023
₹9.15 Lakh ▲ 610%
Net profit · FY 2023
₹1.55 Lakh margin 16.9%
EBITDA · FY 2023
₹2.09 Lakh margin 22.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 610%
EBITDA CAGR growth
1 year
▲ 451%
Revenue rose 610% in the latest year. EBITDA rose 451% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹2.09 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.55 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 22.8% | |
| Net Profit Margin | 16.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kingerly Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kingerly Pharmaceuticals Private Limited
Kingerly Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikha Nilesh Borkar | Director | 17 May 2021 | 5 Years 5 Months | Current |
| Nilesh Tulshidas Borkar | Director | 17 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Kingerly Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrine Pharmaceuticals Private Limited | ₹9.15 Lakh (FY 2025) | 8.0% | Faridabad, Haryana, India | |||
| Kingerly Pharmaceuticals Private Limitedthis company | ₹9.15 Lakh (FY 2023) | ₹1.55 Lakh | 16.9% | 610.0% | Nagpur, Maharashtra, India | |
| Exevant Pharmaceuticals Private Limited | ₹9.12 Lakh (FY 2025) | 7.0% | Sikar, Rajasthan, India | |||
| Sigmavet Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | Raebareilly, Uttar Pradesh, India | ||||
| Atbu Harita Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | -9.0% | Vyara, Gujarat, India |
To see the full peer comparison of Kingerly Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2023 | 100847471 | State Bank of India | ₹3 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Kingerly Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by State Bank of India Through Principal Officer | Pending |
To see the full case history of Kingerly Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kingerly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kingerly Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kingerly Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nilesh Tulshidas Borkar was appointed as Director on 17 May 2021.
Charges
A charge with State Bank Of India amounted to Rs. 3.00 Lakh with Charge ID 100847471 was registered on 22 Dec 2023.
AGM
Kingerly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Kingerly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Nagpur.
Appointed
Nilesh Tulshidas Borkar was appointed as Director.
Appointed
Shikha Nilesh Borkar was appointed as Director.
Incorporation
17 May 2021
Kingerly Pharmaceuticals Private Limited was registered on 17 May 2021 with Roc Nagpur & aged 5 years 5 months as per MCA records.
Frequently asked questions
Kingerly Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 17 May 2021 (5+ years old) and is registered under CIN U24230MH2021PTC360553.
Kingerly Pharmaceuticals has 2 current directors:
- Shikha Nilesh Borkar - Director
- Nilesh Tulshidas Borkar - Director
The latest financial statements of Kingerly Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Kingerly Pharmaceuticals is U24230MH2021PTC360553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kingerly Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Kingerly Pharmaceuticals was incorporated on 17 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Kingerly Pharmaceuticals by revenue are Shrine Pharmaceuticals Private Limited, Exevant Pharmaceuticals Private Limited, Sigmavet Pharmaceuticals Private Limited, Atbu Harita Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nilesh Tulshidas Borkar was appointed as Director on 17 May 2021. Shikha Nilesh Borkar was appointed as Director on 17 May 2021.
Yes, Kingerly Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Kingerly Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0034236).
The registered office of Kingerly Pharmaceuticals is at Plot No. 4A 2nd Floor Marartoli Kamptee, Nagpur, Maharashtra, India – 441001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages